Edgewater Capital Partners Completes Sale of ChemQuest Chemicals to Seatex

Cleveland, OH – Sept. 19, 2022 Edgewater Capital Partners (“Edgewater”), a private equity firm focused on investing in performance materials and services businesses, today announced the sale of ChemQuest Chemicals, LLC (“ChemQuest”), a custom chemical manufacturer headquartered in Pasadena, Texas, to Seatex, LLC (“Seatex”).

“For over 25 years, ChemQuest has provided custom toll manufacturing services to customers globally,” said ChemQuest CEO, Clay Pace. “Since Edgewater’s investment in 2015, we’ve significantly improved the business and successfully positioned it for its next phase of growth. Edgewater has been a supportive partner investing in the Company’s capabilities and team in order to expand our market position.”

“We are appreciative of Clay and the ChemQuest team’s tireless efforts in expanding the business through our ownership,” said Edgewater Partner, Pete Ostergard. “We are excited about the great potential for the Company as part of the Seatex platform and look forward to tracking their continued growth.”

Edgewater retained Taft Stettinius & Hollister LLP as legal counsel, and FMI Capital Advisors served as exclusive financial advisor to ChemQuest and Edgewater.

About Edgewater Capital Partners

Edgewater Capital Partners, headquartered in Cleveland, Ohio, is a sector-focused private equity firm investing in lower middle-market performance materials and services businesses. Edgewater has extensive experience and expertise in the specialty industrials, advanced materials, specialty chemicals, and life sciences sectors. Over twenty years of industry-specific investing has allowed the firm to develop a deep understanding of the complexities and nuances common to these businesses. The Edgewater Difference is summarized by its three foundational pillars: deep sector expertise, Midwestern values and culture, and growth-enabling philosophy. For more information on Edgewater Capital Partners, visit https://www.edgewatercapital.com/.

Back to News